walk-ins when available) Price: $299 Safety & Considerations Not for individuals with certain heart conditions, uncontrolled high blood pressure, severe kidney or liver disease, or pregnancy without clinician approval
Kudoh Y, Shoji T, Oimatsu H, Yoshida S, Kikuchi K, Iimura O (1983) The role of L-carnitine in the pathogenesis of cardiomegaly in patients with chronic hemodialysis
doi: 10.3109/13880209.2013.767361 272 Garca-LafuenteAMoroCManchnNGonzalo-RuizAVillaresAGuillamnEet al
For NAD + and NADH assays, 20 L (for NAD + assay) or 30 L (for NADH assay) of the neutralized sample extract was combined with 90 L of assay mix consisting of 50 L of 0.1 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) with 2 mM EDTA (pH 7.5), 20 L of 1.2 mM 2,6-dichlorophenolindophenol, 10 L of 20 mM phenazine methosulfate, and 10 L of 2,500 units mL 1 aldolase dehydrogenase